Transient Transfection Methods for Clinical Adeno-Associated Viral Vector Production
- 1 July 2009
- journal article
- review article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 20 (7), 698-706
- https://doi.org/10.1089/hum.2009.064
Abstract
Recombinant adeno-associated virus (AAV)-based vectors expressing therapeutic gene products have shown great potential for human gene therapy. One major challenge for translation of promising research to clinical development is the manufacture of sufficient quantities of AAV vectors that meet stringent standards for purity, potency, and safety required for human parenteral administration. Several methods have been developed to generate recombinant AAV in cell culture, each offering distinct advantages. Transient transfection-based methods for vector production are reviewed here, with a focus on specific considerations for development of AAV vectors as clinical products.Keywords
This publication has 73 references indexed in Scilit:
- Undetectable Transcription of cap in a Clinical AAV Vector: Implications for Preformed Capsid in Immune ResponsesMolecular Therapy, 2009
- Coexpression of acidic fibroblast growth factor enhances specific productivity and antibody titers in transiently transfected HEK293 cellsNew Biotechnology, 2008
- Safety and Efficacy of Gene Transfer for Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cellsBiotechnology Letters, 2007
- Adeno-Associated Virus Type 2 (AAV2) Capsid-Specific Cytotoxic T Lymphocytes Eliminate Only Vector-Transduced Cells Coexpressing the AAV2 Capsid In VivoJournal of Virology, 2007
- Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectivesBiotechnology Letters, 2007
- Control of Splicing Efficiency by the Mouse Histone H2a Element in a Murine Leukemia Virus–based Retroviral VectorMolecular Therapy, 2007
- Scalable production of adeno‐associated virus type 2 vectors via suspension transfectionBiotechnology & Bioengineering, 2006
- Treatment of human disease by adeno-associated viral gene transferHuman Genetics, 2006
- Cell Lines for the Production of Recombinant Adeno-Associated VirusHuman Gene Therapy, 1995